Entera Bio (ENTX) Tax Provisions (2021 - 2024)

Entera Bio (ENTX) has reported Tax Provisions for 4 consecutive years, with $14000.0 the latest figure, recorded in Q4 2024.

• Quarterly Tax Provisions changed N/A year-over-year to $14000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43000.0 (up 48.28% YoY) and the FY2024 annual result came in at $14000.0, down 51.72% from the prior year.
• Tax Provisions retreated to $14000.0 in Q4 2024 per ENTX's latest filing, from $29000.0 in the prior quarter.
• Over the last five years, Tax Provisions for ENTX reached as high as $194000.0 in Q3 2022 and fell as low as -$46000.0 in Q4 2022.
• A 4-year average of $12100.0 and a median of -$10000.0 in 2021 frame the typical range for Tax Provisions.
• The largest YoY upside for Tax Provisions was 1592.31% in 2022 against a maximum downside of 206.67% in 2022.
• Year by year, Tax Provisions stood at -$15000.0 in 2021, then slumped by 206.67% to -$46000.0 in 2022, then surged by 163.04% to $29000.0 in 2023, then tumbled by 51.72% to $14000.0 in 2024.
• According to Business Quant data, Tax Provisions over the past three periods registered $14000.0, $29000.0, and -$46000.0 for Q4 2024, Q3 2023, and Q4 2022 respectively.